{"id":128620,"date":"2023-12-16T18:47:07","date_gmt":"2023-12-16T18:47:07","guid":{"rendered":"https:\/\/dailytalks.org\/?p=128620"},"modified":"2023-12-16T18:47:07","modified_gmt":"2023-12-16T18:47:07","slug":"crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=128620","title":{"rendered":"CRISPR-based gene editing therapy approved by the FDA for the first time"},"content":{"rendered":"<p>In a landmark decision, the FDA greenlit two new drugs for the treatment of sickle cell disease in patients 12 and older, one of which \u2014Vertex\u2019s drug Casgevy \u2014 is the first approved use of genome editing technology CRISPR in the US. Bluebird Bio\u2019s Lyfgenia also is a cell-based gene therapy&#8230;<br \/><a href=\"https:\/\/www.engadget.com\/crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time-200726474.html?src=rss\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>In a landmark decision, the FDA greenlit two new drugs for the treatment of sickle<\/p>\n","protected":false},"author":1,"featured_media":128621,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-128620","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time.jpg",1200,1039,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time-150x150.jpg",150,150,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time-300x260.jpg",300,260,true],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time-768x665.jpg",640,554,true],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time-1024x887.jpg",640,554,true],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time.jpg",1200,1039,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time.jpg",1200,1039,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time-1024x887.jpg",1024,887,true],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time-825x575.jpg",825,575,true],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2023\/12\/128620-crispr-based-gene-editing-therapy-approved-by-the-fda-for-the-first-time-590x410.jpg",590,410,true]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=35\" rel=\"category\">Tech<\/a>","tag_info":"Tech","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/128620","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=128620"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/128620\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/128621"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=128620"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=128620"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=128620"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}